Penicillin G Benzathine Injection shortage
Current 4 presentations · 2 manufacturers · first FDA posting 2023-04-26 · last update 2026-09-21
Manufacturers: Laboratorios Atral, Pfizer Inc.
Stated reasons (per FDA): Other
Presentations
| Presentation | Manufacturer | Status | Reason | Notes (FDA) | Dates |
|---|---|---|---|---|---|
| Lentocilin, Injection, 1200000 U/4 mL (NDC 84383-110-01) | Laboratorios Atral | Current Available |
— | Posted 04/26/2023 Updated 09/15/2026 | |
| Bicillin L-A, Injection, 600000 [iU]/1 mL (NDC 60793-700-10) | Pfizer Inc. | Current Unavailable |
Other | Next Delivery and Estimated Recovery: 4Q 2027; Manufacturing delay | Posted 04/26/2023 Updated 09/21/2026 |
| Bicillin L-A, Injection, 1200000 [iU]/2 mL (NDC 60793-701-10) | Pfizer Inc. | Current Limited Availability |
Other | Next Delivery: Fourth Quarter 2026 Estimated Recovery: 3Q 2027; Manufacturing delay | Posted 04/26/2023 Updated 09/21/2026 |
| Bicillin L-A, Injection, 2400000 [iU]/4 mL (NDC 60793-702-10) | Pfizer Inc. | Current Limited Availability |
Other | Next Delivery: Fourth Quarter 2026 Estimated Recovery: 3Q 2027; Manufacturing delay | Posted 04/26/2023 Updated 09/21/2026 |
Get the weekly shortage roundup: a free email of FDA shortage changes (open form)